![](/img/cover-not-exists.png)
Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial
Welt, A., Marschner, N., Lerchenmueller, C., Decker, T., Steffens, C.-C., Koehler, A., Depenbusch, R., Busies, S., Hegewisch-Becker, S.Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-016-3727-x
Date:
February, 2016
File:
PDF, 1.56 MB
english, 2016